KRISTA ZIESMAN: Open Payments
NPI 1518338318 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,466 in 143 payments from 26 companies in 2025. Trend: 2023 $3,282 · 2024 $3,217 · 2025 $3,466
Food & beverage: $3,466
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 30 | $563 |
| Grifols USA, LLC | 12 | $353 |
| Insmed, Inc. | 10 | $280 |
| GENZYME CORPORATION | 9 | $271 |
| AstraZeneca Pharmaceuticals LP | 11 | $236 |
| ANI Pharmaceuticals, Inc. | 10 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $179 |
| JAZZ PHARMACEUTICALS INC. | 6 | $177 |
| United Therapeutics Corporation | 7 | $156 |
| Inspire Medical Systems, Inc. | 2 | $144 |
Products named: NUCALA, Prolastin-C Liquid, DUPIXENT, Arikayce, PURIFIED CORTROPHIN GEL, TRELEGY ELLIPTA, XYWAV, INSPIRE.
Industry payments across FL — which companies pay providers there.
